-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The incidence of diabetes continues to increase and shows a trend of younger a.
Diabetes management has been paid more and more attention by the Chinese governme.
0 Market Status
China is the world's largest country with diabet.
China is the world's largest country with diabet.
Diabetes in China is characterized by the "four lows" of awareness rate, treatment rate, control rate, and diagnosis ra.
The status of cardiovascular safety drugs has risen significant.
Note: HbA1c: glycosylated hemoglobin; ASCVD: atherosclerotic cardiovascular disease; HF: heart failure; CKD: chronic kidney disease
Source: Flint Creation Compiled based on public information
Figure 1: Simple Pathway for Hyperglycemia Treatment in Patients with Type 2 Diabetes Source: Guidelines for Prevention and Treatment of Type 2 Diabetes in China (2020 Edition)
0 Market Pattern
0 Market PatternChina's diabetes drug market space is bro.
China's diabetes drug market space is bro.
Figure 2: 2016-2020 China Diabetes Market Scale and Growth Data Source: Frost & Sullivan
The market structure of diabetes drugs in China is quite different from that in the wor.
The market structure of diabetes drugs in China is quite different from that in the wor.
Figure 3: 2020 China and Global Diabetes Drugs Market Structure Distribution Data Source: Frost & Sullivan
0 Trend
0 TrendInsulin centralized procurement and superimposed new drug patents have expired one after another, and domestic substitution has accelerat.
Insulin centralized procurement and superimposed new drug patents have expired one after another, and domestic substitution has accelerat.
Multiple advantages have been recognized, and new drugs such as GLP-1 will seize the mark.
Combination medication has become an important treatment method, and compound hypoglycemic drugs will usher in rapid grow.
The generic drug market is extremely competitive, and domestic innovative drug research and development has ushered in an upsur.
Data source: Flint Creation Database
references:
references:International Diabetes Federati.
International Diabetes Federati.
IDF Diabetes Atlas, 10th e.
Brussels,Belgium: International Diabetes Federation, 202
Prevalence and Treatment of Diabetes in China, 2013-201 JA.
2021 Dec 28;326(24):2498-250
2021 Dec 28;326(24):2498-250
Guidelines for the prevention and treatment of type 2 diabetes in China (2020 editio.
Chinese Journal of Diabetes, 2021, 13(4): 315-40
Chinese Journal of Diabetes, 2021, 13(4): 315-40